H. Nomura

H. Tsuda, D. Aoki, E. Tominaga, 2013, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

The disease sites of female genital cancers of BRCA1/2-associated hereditary breast and ovarian cancer: a retrospective study

H. Watari, M. Sekine, T. Enomoto, 2021, World Journal of Surgical Oncology.

Prospective feasibility study of neoadjuvant dose-dense paclitaxel plus carboplatin with bevacizumab therapy followed by interval debulking surgery for advanced ovarian, fallopian tube, and primary peritoneal cancer patients

D. Aoki, A. Hirasawa, Yusuke Kobayashi, 2021, International Journal of Clinical Oncology.

Risk factors for lymph node metastasis of ovarian, fallopian tube and primary peritoneal cancer in hereditary breast and ovarian cancer syndrome.

H. Watari, M. Sekine, T. Enomoto, 2020, Japanese journal of clinical oncology.

Efficacy and safety of dose-dense paclitaxel plus carboplatin as neoadjuvant chemotherapy for advanced ovarian, fallopian tube or peritoneal cancer

S. Hashimoto, D. Aoki, A. Hirasawa, 2017, Japanese journal of clinical oncology.

A Retrospective Analysis of the Relationship Between the Result of BRCA1/2 Genetic Testing and Surgical Method Selection in Japan.

M. Sekine, T. Enomoto, S. Akashi-Tanaka, 2020, Clinical breast cancer.

Correlation between the risk of ovarian cancer and BRCA recurrent pathogenic variants in Japan

M. Sekine, T. Enomoto, Seigo Nakamura, 2022, Journal of Human Genetics.

Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan

M. Sekine, T. Enomoto, Seigo Nakamura, 2017, Journal of Human Genetics.

Correction: Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan

M. Sekine, T. Enomoto, Seigo Nakamura, 2018, Journal of Human Genetics.

Expression profiles of carcinosarcoma of the uterine corpus—are these similar to carcinoma or sarcoma?

H. Saya, M. Takano, H. Tsuda, 2012, Genes, chromosomes & cancer.

Synchronous endometrial and ovarian cancer in Lynch syndrome with a MSH2 germline mutation: A case report

Takayuki Takahashi, D. Aoki, E. Tominaga, 2018, Molecular and clinical oncology.

Polymorphisms in the UGT1A1 gene predict adverse effects of irinotecan in the treatment of gynecologic cancer in Japanese patients

K. Kosaki, Y. Tanigawara, T. Zama, 2013, Journal of Human Genetics.

Randomized phase II study comparing docetaxel plus cisplatin, docetaxel plus carboplatin, and paclitaxel plus carboplatin in patients with advanced or recurrent endometrial carcinoma: a Japanese Gynecologic Oncology Group study (JGOG2041).

M. Hatae, N. Yaegashi, I. Konishi, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Randomized phase II study comparing docetaxel plus cisplatin , docetaxel plus carboplatin , and paclitaxel plus carboplatin in patients with advanced or recurrent endometrial carcinoma : a Japanese Gynecologic Oncology Group study ( JGOG 2041 )

M. Hatae, N. Yaegashi, I. Konishi, 2011 .

Clinicopathologic Analysis With Immunohistochemistry for DNA Mismatch Repair Protein Expression in Synchronous Primary Endometrial and Ovarian Cancers

D. Aoki, E. Tominaga, A. Hirasawa, 2014, International Journal of Gynecologic Cancer.

A Comparison of Dye Versus Fluorescence Methods for Sentinel Lymph Node Mapping in Endometrial Cancer

D. Aoki, A. Hirasawa, N. Susumu, 2017, International Journal of Gynecologic Cancer.

Paclitaxel and Carboplatin in Patients With Completely or Optimally Resected Carcinosarcoma of the Uterus: A Phase II Trial by the Japanese Uterine Sarcoma Group and the Tohoku Gynecologic Cancer Unit

M. Shimada, H. Katabuchi, N. Yaegashi, 2015, International Journal of Gynecologic Cancer.

Effect of obesity on operative outcomes of laparoscopic surgery in patients with early stage endometrial cancer

D. Aoki, W. Yamagami, H. Nomura, 2019, JAPANESE JOURNAL OF GYNECOLOGIC AND OBSTETRIC ENDOSCOPY.

Role of Circulating Free Alu DNA in Endometrial Cancer

H. Tsuda, D. Aoki, N. Susumu, 2012, International Journal of Gynecologic Cancer.

The importance of para-aortic lymph nodes in sentinel lymph node mapping for endometrial cancer by using hysteroscopic radio-isotope tracer injection combined with subserosal dye injection: Prospective study.

D. Aoki, N. Susumu, W. Yamagami, 2016, Gynecologic oncology.

Intermittent pneumatic compression for prevention of pulmonary thromboembolism after gynecologic surgery

D. Aoki, N. Susumu, H. Nomura, 2005, Thrombosis journal.

Elevated preoperative neutrophil : lymphocyte ratio as a preoperative indicator of mature cystic teratoma with malignant transformation

S. Hashimoto, D. Aoki, N. Susumu, 2017, The journal of obstetrics and gynaecology research.

Endometrial Cancer as a Familial Tumor: Pathology and Molecular Carcinogenesis (Review)

D. Aoki, A. Hirasawa, N. Susumu, 2009, Current genomics.

UGT1A1 polymorphism as a prognostic indicator of stage I ovarian clear cell carcinoma patients treated with irinotecan

T. Mushiroda, D. Aoki, E. Tominaga, 2017, Japanese journal of clinical oncology.

Progestin therapy for endometrial cancer: the potential of fourth-generation progestin (review).

D. Aoki, N. Susumu, K. Masuda, 2012, International journal of oncology.

Aurora kinase inhibitors: Potential molecular-targeted drugs for gynecologic malignant tumors.

D. Aoki, E. Tominaga, N. Susumu, 2013, Biomedical reports.

The sensitivity and specificity of a new formula to distinguish endometrioid type endometrial carcinoma from ovarian endometrial carcinoma.

Y. Ohnishi, M. Hatae, H. Tsuda, 2010, European journal of obstetrics, gynecology, and reproductive biology.

Comparison of photoselective vaporization and standard transurethral resection of the prostate on urodynamics in patients with benign prostatic hyperplasia

S. Naito, H. Nomura, N. Seki, 2009, International journal of urology : official journal of the Japanese Urological Association.

Photoselective vaporization of the prostate: Outcome according to the prostate size in a series of 102 Japanese patients

S. Naito, H. Nomura, N. Seki, 2009, International journal of urology : official journal of the Japanese Urological Association.

Evaluation of the learning curve for photoselective vaporization of the prostate over the course of 74 cases.

S. Naito, H. Nomura, N. Seki, 2008, Journal of endourology.

Gynecologic Cancer InterGroup (GCIG) Consensus Review for Clear Cell Carcinoma of the Ovary

A. Oza, A. Okamoto, J. Ledermann, 2014, International Journal of Gynecologic Cancer.

Expression of potential biomarkers associated with homologous recombination repair in patients with ovarian or triple-negative breast cancer.

C. Harbron, D. Hodgson, M. O’Connor, 2016, Cancer biomarkers : section A of Disease markers.

Family history and BRCA1/BRCA2 status among Japanese ovarian cancer patients and occult cancer in a BRCA1 mutant case.

K. Kosaki, D. Aoki, E. Tominaga, 2014, Japanese journal of clinical oncology.

Features of ovarian cancer in Lynch syndrome (Review).

D. Aoki, E. Tominaga, A. Hirasawa, 2014, Molecular and clinical oncology.

Current status of molecular-targeted drugs for endometrial cancer (Review)

D. Aoki, E. Tominaga, N. Susumu, 2013, Molecular and clinical oncology.

Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial.

A. Okamoto, S. Pignata, Kiyoko Kato, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase II evaluation of temsirolimus in combination with carboplatin and paclitaxel followed by temsirolimus consolidation as first-line therapy in the treatment of stage III-IV clear cell carcinoma of the ovary.

M. Yunokawa, D. Gershenson, H. Nomura, 2016 .

Association of epigenetic inactivation of the WRN gene with anticancer drug sensitivity in cervical cancer cells

D. Aoki, E. Tominaga, N. Susumu, 2012, Oncology reports.

A tumor of the uterine cervix with a complex histology in a Peutz-Jeghers syndrome patient with genomic deletion of the STK11 exon 1 region.

D. Aoki, A. Hirasawa, N. Susumu, 2014, Future oncology.

Biomarkers in endometrial cancer: Possible clinical applications (Review).

D. Aoki, E. Tominaga, N. Susumu, 2012, Oncology letters.

Characterization of the STK11 splicing variant as a normal splicing isomer in a patient with Peutz–Jeghers syndrome harboring genomic deletion of the STK11 gene

K. Kosaki, Kumiko Misu, D. Aoki, 2016, Human Genome Variation.

Prevalence of pathogenic germline variants detected by multigene sequencing in unselected Japanese patients with ovarian cancer

H. Tsuda, K. Masuda, I. Imoto, 2017, Oncotarget.

MicroRNA and endometrial cancer: Roles of small RNAs in human tumors and clinical applications (Review).

Yusuke Kobayashi, Kouji Banno, Nobuyuki Susumu, 2010, Oncology letters.

Simultaneous analysis of the gene expression profiles of cancer and stromal cells in endometrial cancer

S. Hashimoto, M. Takano, H. Tsuda, 2014, Genes, chromosomes & cancer.

Efficacy and safety of nivolumab in Japanese patients with uterine cervical cancer, uterine corpus cancer, or soft tissue sarcoma: Multicenter, open‐label phase 2 trial

K. Tamura, H. Mukai, K. Hasegawa, 2019, Cancer science.

Recent findings on epigenetic gene abnormalities involved in uterine cancer.

D. Aoki, E. Tominaga, Yusuke Kobayashi, 2017, Molecular and clinical oncology.

Endometrial Cancer and Hypermethylation: Regulation of DNA and MicroRNA by Epigenetics

D. Aoki, N. Susumu, K. Masuda, 2012, Biochemistry research international.

Sentinel Node Navigation Surgery for Endometrial Cancer

D. Aoki, A. Hirasawa, N. Susumu, 2019, Comprehensive Gynecology and Obstetrics.

Epidemiology and Etiology of Ovarian Cancer

D. Aoki, H. Nomura, Y. Nanki, 2017 .

A phase I study of combined trabectedin and pegylated liposomal doxorubicin therapy for advanced relapsed ovarian cancer

M. Ono, M. Yunokawa, K. Tamura, 2021, International Journal of Clinical Oncology.

Experience with Ureteral Stone Management in 1,082 Patients Using Semirigid Ureteroscopes

H. Nomura, T. Igarashi, T. Oikawa, 2000, Urologia Internationalis.

Epimutation and cancer: A new carcinogenic mechanism of Lynch syndrome

D. Aoki, E. Tominaga, N. Susumu, 2012, International journal of oncology.

Is repeated high-dose medroxyprogesterone acetate (MPA) therapy permissible for patients with early stage endometrial cancer or atypical endometrial hyperplasia who desire preserving fertility?

D. Aoki, A. Hirasawa, N. Susumu, 2018, Journal of gynecologic oncology.

A randomized phase III trial of docetaxel plus cisplatin or paclitaxel plus carboplatin compared with doxorubicin plus cisplatin as adjuvant chemotherapy for endometrial cancer at high risk of recurrence: Japanese Gynecologic Oncology Group study (JGOG2043).

K. Ushijima, N. Yaegashi, D. Aoki, 2017 .

Clinical implications of next‐generation sequencing‐based panel tests for malignant ovarian tumors

D. Aoki, N. Susumu, W. Yamagami, 2020, Cancer medicine.

Aberrant DNA Methylation in Endometrial Cancer

D. Aoki, A. Hirasawa, N. Susumu, 2012 .

Application of MicroRNA in Diagnosis and Treatment of Ovarian Cancer

D. Aoki, E. Tominaga, K. Masuda, 2014, BioMed research international.

Epigenetic Aberrant Hypermethylation of DNA in Endometrial Cancer: Application as a Biomarker

D. Aoki, N. Susumu, K. Masuda, 2011 .

Long-term outcome of hand-assisted laparoscopic radical nephrectomy for localized stage T1/T2 renal-cell carcinoma.

K. Tatsugami, S. Naito, H. Nomura, 2005, Journal of endourology.

[A clinicopathological evaluation of prognostic factors of urothelial tumors of the renal pelvis and ureter].

H. Nomura, T. Oikawa, M. Nokubi, 2001, Hinyokika kiyo. Acta urologica Japonica.

Drug repositioning of mevalonate pathway inhibitors as antitumor agents for ovarian cancer

H. Kashima, D. Aoki, E. Tominaga, 2017, Oncotarget.

Pathology-oriented treatment strategy of malignant ovarian tumor in pregnant women: analysis of 41 cases in Japan

H. Yoshikawa, T. Jobo, Y. Takei, 2014, International Journal of Clinical Oncology.

Expression of NEU3 (plasma membrane-associated sialidase) in clear cell adenocarcinoma of the ovary: its relationship with T factor of pTNM classification.

T. Irimura, D. Aoki, N. Susumu, 2006, Oncology research.

Analysis of candidate target genes for mononucleotide repeat mutation in microsatellite instability-high (MSI-H) endometrial cancer.

D. Aoki, A. Hirasawa, N. Susumu, 2009, International journal of oncology.

Epigenetic DNA hypermethylation: clinical applications in endometrial cancer (Review).

D. Aoki, A. Hirasawa, N. Susumu, 2009, Oncology reports.

EGRI and FOSB gene expressions in cancer stroma are independent prognostic indicators for epithelial ovarian cancer receiving standard therapy

Hiroshi Nishio, Hiroshi Tsuda, Daisuke Aoki, 2012, Genes, chromosomes & cancer.

GSTP1 rs1695 is associated with both hematological toxicity and prognosis of ovarian cancer treated with paclitaxel plus carboplatin combination chemotherapy: a comprehensive analysis using targeted resequencing of 100 pharmacogenes

T. Mushiroda, D. Aoki, A. Hirasawa, 2018, Oncotarget.

Metformin: A possible drug for treatment of endometrial cancer

D. Aoki, N. Susumu, K. Masuda, 2012 .

Lymph Node Metastasis in Grossly Apparent Stages I and II Epithelial Ovarian Cancer

H. Tsuda, D. Aoki, E. Tominaga, 2009, International Journal of Gynecologic Cancer.

Comparison of photoselective vaporization and standard transurethral resection of the prostate on urodynamics in patients with benign prostatic hyperplasia

S. Naito, H. Nomura, N. Seki, 2009, International journal of urology : official journal of the Japanese Urological Association.

Carcinoma of the Lower Uterine Segment (LUS): Clinicopathological Characteristics and Association with Lynch Syndrome

D. Aoki, A. Hirasawa, N. Susumu, 2011, Current genomics.

Relationship of lower uterine segment cancer with Lynch syndrome: A novel case with an hMLH1 germline mutation

D. Aoki, E. Tominaga, A. Hirasawa, 2012, Oncology reports.

Clinical management of epithelial ovarian cancer

D. Aoki, E. Tominaga, Yusuke Kobayashi, 2018 .

Analysis of a correlation between the BRAF V600E mutation and abnormal DNA mismatch repair in patients with sporadic endometrial cancer.

M. Kobayashi, D. Aoki, A. Hirasawa, 2009, International journal of oncology.

Effects of third-line chemotherapy for women with recurrent ovarian cancer who received platinum/taxane regimens as first-line chemotherapy.

D. Aoki, E. Tominaga, N. Susumu, 2010, European Journal of Gynaecological Oncology.

Can ABCF2 protein expression predict the prognosis of uterine cancer?

Y. Miyagi, D. Aoki, A. Hirasawa, 2008, British Journal of Cancer.

Glycan profiling of gestational choriocarcinoma using a lectin microarray.

H. Saya, D. Aoki, E. Tominaga, 2014, Oncology reports.

Omental herniation through 5-mm trocor site after laparoscopic myomectomy

D. Aoki, H. Nomura, F. Kataoka, 2011 .

Effectiveness of third-line chemotherapy in recurrent ovarian cancer patients.

S. Hashimoto, D. Aoki, E. Tominaga, 2015, European Journal of Gynaecological Oncology.

Relationship between DNA Mismatch Repair Deficiency and Endometrial Cancer

D. Aoki, A. Hirasawa, N. Susumu, 2011, Molecular biology international.

Hand-Assisted Laparoscopic Radical Nephrectomy for Renal Cancer

S. Naito, H. Nomura, Masatoshi Tanaka, 2004 .

DNA Mismatch Repair (MMR) Genes and Endometrial Cancer

D. Aoki, A. Hirasawa, N. Susumu, 2011 .

Multicenter Clinicopathological Study of High-Grade Serous Carcinoma Presenting as Primary Peritoneal Carcinoma

D. Aoki, Y. Udagawa, H. Nomura, 2018, International Journal of Gynecologic Cancer.

Retrospective Analysis on the Feasibility and Efficacy of Docetaxel-Cisplatin Therapy for Recurrent Endometrial Cancer.

D. Aoki, A. Hirasawa, N. Susumu, 2016, Anticancer research.

The treatment of uterine leiomyosarcoma: clinical outcomes of 18 cases and the effectiveness of chemotherapy.

H. Iwase, H. Nomura, N. Takeshima, 2011, European Journal of Gynaecological Oncology.

Intermittent pneumatic compression for prevention of pulmonary thromboembolism after gynecologic surgery

D. Aoki, N. Susumu, H. Nomura, 2005, Thrombosis journal.

Family history and BRCA1/BRCA2 status among Japanese ovarian cancer patients and occult cancer in a BRCA1 mutant case.

K. Kosaki, D. Aoki, E. Tominaga, 2014, Japanese Journal of Clinical Oncology.

Glycan profiling of gestational choriocarcinoma using a lectin microarray.

H. Saya, D. Aoki, E. Tominaga, 2014, Oncology reports.

Efficacy and safety of nivolumab (Nivo) in patients (pts) with advanced or recurrent uterine cervical or corpus cancers.

K. Tamura, H. Mukai, H. Nomura, 2018 .

Amplification of GNAS may be an independent, qualitative, and reproducible biomarker to predict progression-free survival in epithelial ovarian cancer.

K. Nishio, M. Takano, H. Tsuda, 2010, Gynecologic oncology.